These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26577959)

  • 21. Transfusion-transmitted bacterial infection: risks, sources and interventions.
    Wagner SJ
    Vox Sang; 2004 Apr; 86(3):157-63. PubMed ID: 15078249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Managing the microbiological safety of blood for transfusion: a US perspective.
    Dodd R
    Future Microbiol; 2009 Sep; 4(7):807-18. PubMed ID: 19722836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Biotest position on HIV-1 seroconversions in 1990 in 11 patients, treated with beta-propiolactone/uv virus inactivated PPSB].
    Pustoslemsek P; Kloft M; Kotitschke R
    Infusionsther Transfusionsmed; 1993 Dec; 20(6):344-6. PubMed ID: 8142739
    [No Abstract]   [Full Text] [Related]  

  • 24. Patient-to-patient transmission of bloodborne pathogens in health care: the price and perils of progress?
    Henderson DK
    Infect Control Hosp Epidemiol; 2008 Apr; 29(4):294-6. PubMed ID: 18462139
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of pathogen inactivation on the storage lesion in red cells and platelet concentrates.
    Seghatchian J; Hervig T; Putter JS
    Transfus Apher Sci; 2011 Aug; 45(1):75-84. PubMed ID: 21782517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The risks associated with blood and blood product transfusion.
    Higgins C
    Br J Nurs; 2000 Dec 8-2001 Jan 10; 9(22):2281-90. PubMed ID: 12271194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pathogen reduction for platelets: a debate].
    Moncharmont P; Py JY
    Transfus Clin Biol; 2011 Aug; 18(4):498-501. PubMed ID: 21715209
    [No Abstract]   [Full Text] [Related]  

  • 28. [Orthopoxviruses: infections in humans. Position of the Blood Working Group of the Federal Ministry of Health].
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Sep; 53(9):957-72. PubMed ID: 20853093
    [No Abstract]   [Full Text] [Related]  

  • 29. Towards the holy grail of the infection-free blood transfusion.
    Barbara J; Eglin R; Mortimer PP
    Commun Dis Public Health; 2004 Mar; 7(1):8-10. PubMed ID: 15137274
    [No Abstract]   [Full Text] [Related]  

  • 30. Pathogen inactivation: coming of age.
    Lozano M; Cid J
    Curr Opin Hematol; 2013 Nov; 20(6):540-5. PubMed ID: 24104416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infection control. It's in the blood.
    Kenny C
    Nurs Times; 2002 Aug; 98(34):12-3. PubMed ID: 12239854
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pathogen inactivation of platelets: organization consequences for platelet transfusion].
    Chavarin P; DePutter C; Boussoulade F; Acquart S; Vidal M; Argaud C; Fabrigli P; Garraud O
    Transfus Clin Biol; 2011 Aug; 18(4):472-7. PubMed ID: 21783400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beyond HIV, HBV and HCV--how to deal with other viruses?
    Minor PD
    Dev Biol (Basel); 2002; 108():15-9. PubMed ID: 12220138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogen Reduction: The State of the Science in 2019.
    Gehrie EA; Rutter SJ; Snyder EL
    Hematol Oncol Clin North Am; 2019 Oct; 33(5):749-766. PubMed ID: 31466602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Towards bacterial detection in labile blood products].
    Morel P
    Transfus Clin Biol; 2005 Jun; 12(2):215-20. PubMed ID: 15894499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Blood transfusion and blood product risks and alternatives (from the civil law viewpoint of the judge)].
    Schlund GH
    Geburtshilfe Frauenheilkd; 1994 Oct; 54(10):M133-6. PubMed ID: 8001747
    [No Abstract]   [Full Text] [Related]  

  • 37. [Infection hazard due to blood or blood components].
    Frenzel H; Lefèvre H
    Dtsch Med Wochenschr; 1993 Sep; 118(37):1341; author reply 1344. PubMed ID: 8375311
    [No Abstract]   [Full Text] [Related]  

  • 38. [Risks of infection caused by blood and blood products with reference to the so-called AIDS scandal].
    Kretschmer V
    Infusionsther Transfusionsmed; 1993 Dec; 20(6):286-90. PubMed ID: 8142734
    [No Abstract]   [Full Text] [Related]  

  • 39. [Transfusion of blood and blood derivatives. Measurements of safety, circulatory, immunologic and infectious risks and accidents].
    Rouger P; Hergon E
    Rev Prat; 1997 Sep; 47(13):1499-504. PubMed ID: 9339033
    [No Abstract]   [Full Text] [Related]  

  • 40. Fifty years of blood transfusion.
    Gunson HH; Dodsworth H
    Transfus Med; 1996; 6 Suppl 1():1-88. PubMed ID: 8870182
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.